R. Alexandra Keith Sells 855 Shares of The Procter & Gamble Company (NYSE:PG) Stock

The Procter & Gamble Company (NYSE:PG - Get Free Report) CEO R. Alexandra Keith sold 855 shares of the business's stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total transaction of $135,517.50. Following the sale, the chief executive officer now directly owns 4,004 shares of the company's stock, valued at $634,634. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

R. Alexandra Keith also recently made the following trade(s):

  • On Monday, March 4th, R. Alexandra Keith sold 776 shares of Procter & Gamble stock. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36.

Procter & Gamble Stock Performance

PG opened at $161.50 on Wednesday. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $163.14. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.48. The company has a market cap of $380.01 billion, a P/E ratio of 26.39, a price-to-earnings-growth ratio of 3.19 and a beta of 0.44. The firm's 50-day moving average price is $159.32 and its 200-day moving average price is $153.26.


Gold Mania
Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).
See his free reveal right here.


Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Friday, April 19th. The company reported $1.52 EPS for the quarter, beating analysts' consensus estimates of $1.42 by $0.10. The firm had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. Procter & Gamble had a return on equity of 33.77% and a net margin of 18.00%. Procter & Gamble's revenue for the quarter was up .6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.37 earnings per share. As a group, equities analysts anticipate that The Procter & Gamble Company will post 6.53 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a $1.0065 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.49%. This is a positive change from Procter & Gamble's previous quarterly dividend of $0.94. Procter & Gamble's dividend payout ratio is currently 65.69%.

Institutional Investors Weigh In On Procter & Gamble

A number of large investors have recently bought and sold shares of the company. Wellington Management Group LLP boosted its position in Procter & Gamble by 9.4% in the third quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company's stock valued at $5,193,916,000 after buying an additional 3,047,557 shares during the last quarter. Northern Trust Corp boosted its position in Procter & Gamble by 2.3% in the 3rd quarter. Northern Trust Corp now owns 29,313,150 shares of the company's stock worth $4,275,616,000 after purchasing an additional 670,862 shares in the last quarter. Norges Bank purchased a new stake in Procter & Gamble in the 4th quarter worth approximately $3,956,117,000. Charles Schwab Investment Management Inc. boosted its position in Procter & Gamble by 1.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 16,209,425 shares of the company's stock worth $2,336,552,000 after purchasing an additional 206,165 shares in the last quarter. Finally, Royal Bank of Canada boosted its position in Procter & Gamble by 3.2% in the 3rd quarter. Royal Bank of Canada now owns 11,170,305 shares of the company's stock worth $1,629,299,000 after purchasing an additional 346,925 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.

Analyst Upgrades and Downgrades

PG has been the subject of several recent research reports. UBS Group lifted their price objective on Procter & Gamble from $172.00 to $178.00 and gave the company a "buy" rating in a report on Wednesday, January 24th. Wells Fargo & Company lifted their price objective on Procter & Gamble from $162.00 to $170.00 and gave the company an "overweight" rating in a report on Wednesday, January 24th. Barclays lifted their price objective on Procter & Gamble from $168.00 to $170.00 and gave the company an "overweight" rating in a report on Tuesday. JPMorgan Chase & Co. decreased their price objective on Procter & Gamble from $169.00 to $162.00 and set an "overweight" rating for the company in a report on Thursday, January 18th. Finally, StockNews.com downgraded shares of Procter & Gamble from a "buy" rating to a "hold" rating in a report on Thursday, February 29th. Seven research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. Based on data from MarketBeat, Procter & Gamble presently has a consensus rating of "Moderate Buy" and a consensus target price of $168.88.

Check Out Our Latest Stock Analysis on PG

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Further Reading

Insider Buying and Selling by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Procter & Gamble?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Procter & Gamble and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.

Most Read This Month

Recent Articles